F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today announced the clinical development plan to ...

"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...

The Finn family presents $27,550 fundraising check to Drs. Asher Marks and Vidya Puthenpura at the Pediatric Specialty Center surrounded ...

The family, which owns Westfield Pest Control, is asking the community to help support them during this devastating chapter ...

The Rush got off on the right foot to start 2025, taking two of three games against the Tulsa Oilers last week at The Monument Ice Arena.

The firm has discussed positive Phase I results on BCB-276 with the FDA and plans to move it directly to a registrational trial by year-end.

A TRANSPLANT recipient has died of cancer after contracting the illness from his organ donor. The unnamed patient, 69, from Arizona underwent an organ transplant to treat his liver ...